Table 1 Patient characteristics
From: Quantitative implications of the updated EARL 2019 PET–CT performance standards
Characteristics | Non-small cell lung cancer | Lymphoma | Total |
|---|---|---|---|
Total no. of patients | 13 | 17 | 30 |
Males/females | 6 / 7 | 10 / 7 | 16 / 14 |
Weight of patients (mean) | 42 – 92 (69.4) kg | 61 – 103 (78.9) kg | 42 – 103 (74.8) kg |
BMI of patients (mean) | 18 – 28 (23.3) | 19 – 41 (25.7) | 18 – 41 (24.7) |
Administered activity (mean) | 161 – 314 (240) MBq | 205 – 347 (274) MBq | 161 – 347 (259) MBq |
Total no. of analysed lesions | 19 | 36 | 55 |
Lesions per patient (mean) | 1-3 (1.5) | 1-3 (2.1) | 1-3 (1.8) |